S
HARP

SignatureFD’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

SignatureFD’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15
Closed -$1K – 3326
2021
Q3 		$1K Sell
15
-4
-21% -$402 ﹤0.01% 2976
2021
Q2 		$3K Hold
19
– – ﹤0.01% 2513
2021
Q1 		$4K Buy
+19
New +$3.81K ﹤0.01% 2290

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

SignatureFD's HARP Position: Q4 2021 in Review

SignatureFD sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2021, closing a stake of 15 shares — an estimated $1K sold.

SignatureFD first reported a position in HARP in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q1 2021. 84 funds tracked by Wall St. Rank hold HARP as of Q4 2021.

  • SignatureFD reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • SignatureFD sold 15 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $1K.
  • SignatureFD first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • SignatureFD's Harpoon Therapeutics, Inc. Common Stock position peaked at $4K in Q1 2021.
  • 84 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.